Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Fisiogen Ferro Forte** is an oral dietary iron supplement marketed by Zambon. It provides 30 mg of iron as sucrosomal ferric pyrophosphate, an ultradispersed ferric pyrophosphate formulation enclosed in a Sucrosoma lipid and sucrose-ester matrix, together with vitamin C. The delivery system is intended to protect iron from direct gastric-mucosal exposure and support intestinal absorption and tolerability. It is used to supplement dietary iron in iron-deficiency states or when iron requirements are increased. The product was evaluated as oral liposomal iron in the BARIFER study in women with iron deficiency requiring chronic intravenous iron replacement after Roux-en-Y gastric bypass surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fisiogen Ferro Forte.